A robust method for the preparation and purification of antibody/streptavidin conjugates

Bioconjugate Chemistry

Volumn 12, Issue 3, 2001, Pages 421-427

  Hylarides, Mark D ^a   Mallett, Robert W ^a   Meyer, Damon L ^b  

^a Poniard Pharmaceuticals Inc   (United States)

^b SEATTLE GENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CHROMATOGRAPHIC ANALYSIS; CROSSLINKING; ION CHROMATOGRAPHY; ION EXCHANGE;

ACTIVATED PROTEINS; CLINICAL DEVELOPMENT; CLINICAL EVALUATION; CROSS LINKING AGENTS; DELIVERY SYSTEMS; MALEIMIDES; OXIDIZING AGENTS; PROTEIN CONJUGATES; ROBUST METHODS; STREPTAVIDIN;

SULFUR COMPOUNDS;

EID: 0035019367     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0001286     Document Type: Article

References (35)

1. Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F.-M., Hobson, L. J., Beaumier, P. L., Fritzberg, A. R. (1999) Cure of human carcinoma xenografts by a single dose of pretargeted Yttrium-90 with negligible toxicity. Proc. Natl. Acad. Sci. 97, 1802-1807.
2. Goodwin, D. A., Meares, C. F., McCall, M. J., McTigue, M., and Chaovapong, W. (1988) Pre-targeted immunoscintigraphy of murine tumors with Indium-111 labeled bifunctional haptens. J. Nucl. Med. 29, 226-234.
3. Goodwin, D. A., Meares, C., McCall, M. (1989) Method and system for administering therapeutic and diagnostic doses. U.S. Patent Number 4,863, 713.
4. Kalofonos, H. P., Rusckowski, M., Siebecker, D. A., Sivolapenko, G. B., Snook, D., Lavender, J. P, Epenetos, A. A., and Hnatowich, D. J. (1990) Imaging of tumor in patients with Indium-111 labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J. Nucl. Med, 31, 1791-1796.
5. Axworthy, D. B., Fritzberg, A. R., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F.-M., Beaumier, P. L., and Reno, J. M. (1994) Preclincal evaluation of an antitumor monoclonal antibody/streptavidin conjugate for pretargeted 90Y radioimmunotherapy in a mouse xenograft model. J. Immunother. 16, 158 (abstract).
6. Axworthy, D. B., Beaumier, P. L., Bottino, B., Goshorn, S., Mallett, R. W., Stone, D. M., Su, F. M., Theodore, L. J., Yau, E. K., and Reno, J. M. (1996) Preclinical optimization of pretargeted radioimmunotherapy components: High efficiency, curative 90Y delivery to mouse tumor xenografts. Tumor Target. 2, 156-157 (abstract).
7. Paganelli, G., Malcovati, M. and Fazio, F. (1991) Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system. Nucl. Med. Commun. 12, 211-234.
8. Bamias, A., and Epenetos, A. A. (1992) Two-step strategies for the diagnosis and treatment of cancer with bioconjugates. Antibody, Immunoconjugates, Radiopharm. 5, 385-395.
9. Ngai, W. M., Reilly, R. M., Polhronis, J., Shpitz, B. (1995) In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49. Nucl. Med. Biol 22, 77-86.
10. Sharkey, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R. D., Mattes, J. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model. Bioconjugate Chem. 8, 595-604.
11. Houghton, A. N., and Scheinberg, D. S. (1991) Monoclonal antibodies, in Comprehensive Textbook of Oncology (A. K. Moosa, C. Schimpff, and M. C. Robson, Eds.) p 601, Williams and Wilkins, Baltimore.
12. Mello, A. M., Pauwels, E. K. J., and Cleton, F. J. Radioimmunotherapy: no news from the newcomer. (1994) J. Cancer Res. Clin. Oncol. 120, 121-130.
13. Jain, R. K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271, 58-65.
14. Cassidy, J., Newell, D. R., Wedge, S. R., and Cummings, J. (1993) Pharmacokinetics of high molecular weight agents. Cancer Surveys 17, 315-341.
15. Reilly, R. M., Sandhu, J., Alvarez-Diez, T. M., Gallinger, S., Kirsh, J., and Stern, H. (1995) Problems of delivery of monoclonal antibodies. Clin. Pharmacokinet. 28, 126-142.
16. Knox, S. J. (1995) Overview of studies on experimental radioimmunotherapy, Cancer Res. 55, 5832s-5836s.
17. Karacay, H., Sharkey, R. M., Griffiths, G. L., Govindan, S. V., McBride, W. J., Goldenberg, D. M., and Hansen, H. J. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent Development. Bioconjugate Chem. 8, 585-594.
18. Foulon, C. F., Bigner, D. D., Zalutsky, M. R. (1999) Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting application. Bioconjugate Chem. 10, 867-876.
19. Sheldon, K., Baumal, R., Marks, A. (1992) Targeting of 111In biocytin to cultured ovarian adenocarcinoma cells using covalent monoclonal antibody-streptavidin conjugates. Appl. Radiat. Isot. 43, 1399-1402.
20. Green, N. M. (1965) A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin. Biochem. J. 94, 23C-24C.
21. Weber, P. C., Ohlendorf, D. H., Wnndeloski, J. J., Salemme, F. R. (1989) Structural origins of high-affinity biotin binding to streptavidin, Science 243, 85.
22. Schechter, B., Silberman, R., Aronon, R., Wilchek, M. (1990) Tissue distribution of avidin and streptavidin injected into mice. Eur. J. Biochem. 189, 327-331.
23. Okabe, T., Kaizu, T., Fujisawa, J., Watanabe, J., Kojima, K., Yamashita, T., and Takaku, F. (1984) Monoclonal antibodies to surface antigens of small cell canrinoma of the lung. Cancer Res. 44, 5273-5278.
24. Litvinov, S. V., Velders, M. P., Bakker, H. A. M., Fleuren, G. J., and Warnaar, S. O. (1994) Ep-CAM, A human epithelial antigen is a homophilic cell-cell adhesion molecule. J. Cell Biol. 125, 437-446.
25. Beaumier, PL., Benkatesan, P., Vanderheyden, J.-L., Burgua, W. D., Kunz, L. L., Fritzberg, A. R., Abrams, P. G., and Morgan, A. C. (1991) 186-Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res. 51, 676-681.
26. Breitz, H. B., Weiden, P. W., Vanderheyden, J.-L, Applebaum, J. W., Bjorn, M. J., Fer, M. F., Wolf, S. B., Ratliff, B. A., Seiler, C. A., Foisie, D. C., Fisher, D. R., Schroff, R. W., Fritzberg, A. R., and Abrams, P. G. (1992) Clinical experience with Rhenium-186 labeled monoclonal antibodies for radioimmunotherapy: Results of Phase I trials. J. Nucl. Med. 33, 1099-1109.
27. Graves, S. S., Goshorn, S. C., Stone, D. M., Axworthy, D. B., Reno, J. M., Bottino, B., Searle, S., Henry, A., Pedersen, J., Rees, A. R., and Libby, R. T. (1999) Molecular modeling and preclinical evaluation of the humanized NR-LU-23 antibody. Clin. Canc. Res. 5(4), 899-908.
28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
29. Wyatt, P. J. (1993) Light scattering and the absolute characterization of macromolecules. Anal. Chim. Acta 272, 1-40.
30. Ellman, G. L. (1959) Tissue sulfhydryl groups. Arch Biochem. Biophys. 82, 70-77.
31. Janolino, V. G, Fontecha, J., Swaisgood, H. E. (1996) A spectrophotometric assay for biotin-binding sites of immobilized avidin. Appl. Biochem. Biotech. 56, 1-7.
32. Hashida, S., and Ishikawa, E. (1985) Use of normal IgG and its fragments to lower the nonspecific binding of Fabenzyme conjugates in sandwich enzyme immunoassay. Anal. Lett. 18(B9), 1143-1155.
33. Cleland, E. J., et al. (1947) Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3, 480-482.
34. Hofmann, K., Wood, S. W., Brinton, C. C., Montibeller, J. A., Finn, F. M.(1980) Iminobiotin affinity columns and their application to retrieval of streptavidin, Proc. Natl. Acad. Sci. U.S.A. 77, 4666-4668.
35. Bignami, G. S., Senter, P. D., Grothaus, P. G., Fischer, K. J., Humphreys, T., and Wallace, P. M. (1992) N-(4′-Hydroxyphenylacetyl)palytoxin: A palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate, Cancer Res. 52, 5759-5764.